DGKE and metabolic disease: The current work therefore suggests that organs and enzymes, such as kidney DGKε, which are not typically thought to contribute significantly to circulating LPA may, indeed, be significant sources under certain conditions, and future studies should consider alternate pathways and sites for LPA generation in metabolic disease.